Definitive Contract H9240521C0002
Award Date
12/7/20
Potential Completion Date
9/15/22
Potential Value
$1.9M
Funding Federal Agency
US Special Operations Command
Contracting Federal Agency
Defense Contract Management Agency
Awardee
Mantel Technologies, Inc.
Ultimate Awardee
Mantel Technologies, Inc.
PSC Category
AC13 - National Defense R&D Services; Department Of Defense - Military; Experimental Development
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Fort Collins, CO 80525, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a $1,514,744.00 cost-plus-fixed-fee contract awarded by the United States Special Operations Command (USSOCOM) to Mantel Technologies, Inc., a for-profit small business, under the Small Business Innovation Research (SBIR) program. The contract is for Phase II research and prototype deliverables related to "Freeze Dried Plasma for Canines". Mantel Technologies has a history of providing a range of goods and services to the federal government, including through prime and...
This is a firm-fixed-price purchase order awarded by the U.S. Special Operations Command (SOCOM) to Mantel Technologies, Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) program. The contract is for Phase I research and development on the topic of "Freeze Dried Plasma for Canines" (SOCOM163-007), with a ceiling value of $144,516.60 and an ultimate completion date of July 10, 2017. Mantel Technologies specializes in developing training mannequins,...
The U.S. Defense Health Agency has awarded a $7,733,625.25 cost-plus-fixed-fee contract to Mantel Technologies, Inc. for Phase III Small Business Innovation Research (SBIR) research and development of a "Canine Freeze Dried Plasma System." This definitive contract has a completion date of September 15, 2025. Mantel Technologies, Inc. is a small business manufacturer that has previously received federal contract and grant awards from the Department of Defense and Department of Energy...
Mantel Technologies, Inc. was awarded a $1,638,218.00 cost-plus-fixed-fee SBIR Phase II contract by the United States Special Operations Command (SOCOM) to develop a prototype of a canine remote physiological monitoring system. This small business set-aside contract supports SOCOM's research and development efforts on topics such as physiological monitoring and canine capabilities. Mantel Technologies is a manufacturer and service provider that has delivered a range of products and services to...
The U.S. Department of the Army, Research, Development and Engineering Command (RDECOM) has awarded a $1,149,942.61 Firm Fixed Price contract to Mantel Technologies, Inc., a small business manufacturer located in Fort Collins, Colorado. The contract is for the development of a "Canine VO2max Measurement System" under the Small Business Technology Transfer (STTR) Phase II program. The contract has a completion date of December 31, 2025. Mantel Technologies, Inc. is an established...
This is a $1,599,934.00 cost-plus-fixed-fee contract awarded by the Department of the Navy's Naval Air Systems Command to Mantel Technologies, Inc., a for-profit manufacturing company, for STTR Phase II research and development work. The contract is set aside for small businesses and the work will take place in Fort Collins, CO. Mantel Technologies is the prime contractor and has previously conducted SBIR/STTR research for the Army, Navy, Air Force, and Special Operations Command on topics...
This is a $149,635.86 SBIR Phase I contract awarded by the U.S. Special Operations Command (SOCOM) to Cellphire, Inc., a small business biotechnology company. The contract is for a feasibility study on the development of freeze-dried plasma for use with canines, under SBIR Topic SOCOM163-007. Cellphire has prior experience providing research, development, and manufacturing services for lyophilized canine plasma and cryopreserved human platelets under past Department of Army and Defense Health...
<p>This is a $146,094.30 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Special Operations Command (USSOCOM) to Oxford Biomedical Research, Inc. The contract is for a feasibility study on the topic of "FREEZE DRIED PLASMA FOR CANINES" under SOCOM SBIR Topic 163-007. The contract has a period of performance through July 5, 2017 and is a firm-fixed-price purchase order.</p>
This contract was awarded by the United States Special Operations Command (USSOCOM) to Metro International Biotech, LLC, a small business, for a Feasibility Study under the Small Business Innovation Research (SBIR) Phase I program. The contract's total potential value is $148,612.26 and it is a Firm Fixed Price Purchase Order. The study is focused on the topic of "Enhanced Canine Performance, Protection and Survivability" and was completed on May 29, 2018. The contract was set aside...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a for-profit small business, for a feasibility study on "Enhanced Canine Performance, Protection and Survivability". The contract has a firm fixed price of $99,886.50 and a period of performance from November 21, 2017 to May 21, 2018. As an SBIR Phase I award, this contract is focused on the initial research and development of...